A Reliable and Customizable Solution
Kalypsys is a leading innovator in the area of drug discovery and utilizes some of the most advanced and robust drug discovery automation tools in the industry. The Kalypsys Systems Group was formed to market these tools to researchers in pharmaceutical and academic research institutions. Satisfied Kalypsys’ customers include a number of prestigious organizations including The National Institutes of Health, Los Alamos National Laboratories, The Scripps Research Institute, Florida and Merck Research Laboratories. Purchasing a Kalypsys System means entering into an integrated and user friendly relationship to allow you to expand your technology capabilities as your drug discovery or profiling needs expand. Many of our Systems partners find that they want to integrate new hardware or software capabilities after they purchase their first Kalypsys System, and the Kalypsys Systems Group and the Kalypsys Informatics Team is here to facilitate our partners technology needs.
Reliable Products that Increase Productivity
Kalypsys Systems products include large and small automated robotic systems, a compound transfer workstation, a protein production/purification system, and dispenser droplet detection system and a 1536 well washer/dispenser workstation. This suite of products allows for an increase in productivity and reliability that is unmatched in the area of automated drug discovery.
Kalypsys Systems Power Saturation Discovery
It is the speed and efficiency of Kalypsys’ Systems automated screening and profiling that powers the Saturation Discovery approach – the intensive, highly parallel interrogation of multiple targets in a disease pathway or mechanism. Multi-dimensional hit information is extracted from the tens of millions of data points which are generated by parallel screens in multiple formats and screens for novel MOAs. The optimized chemical leads generated by Saturation Discovery are evaluated via streamlined pharmacological testing funnels that quickly identify the target(s) and lead compound(s) with the greatest efficacy potential and the most attractive side effect profile. Saturation Discovery helps to create robust data packages in support of early termination of discovery programs. This approach ensures that more attractive, pharmaceutically relevant molecules that have a higher chance of success are advanced into the clinic and can help you to advance your programs more effectively as well.
The Kalypsys Technology Partnership with Panasonic
In 2006 Kalypsys, Inc. and Panasonic Factory Solutions Company announced their partnership in to design and market the next generation in drug discovery automation. Panasonic is the world’s #1 company in the R&D of technology, based both on R&D expenditures and patents granted. While well known for its consumer products, Panasonic is also the world’s largest manufacturer of electronic assemblies and a leader in automation for this market. Moreover, Panasonic is also the major supplier of automation to the Japanese life science market, with an installed base of over 50 drug discovery systems. Kalypsys Systems and Panasonic are collaborating not only with each other, but with leading researchers, automation experts, drug discovery scientists, other equipment vendors, and influential thinkers in the life sciences. In the coming months Kalypsys Systems and Panasonic will unveil a new product line developed from the ground up to improve the productivity of researchers in the life sciences. Back to Top